CLINICAL_TRIALS
trial_result
· 2017-04-28
Clinical Trial Update: Effect of a CCK-1R Agonist on Food Intake in Humans [Phase 2]
Summary
Phase 2 trial evaluating a CCK-1R agonist for food intake in bulimia; the study was terminated and results were posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: St. Luke's-Roosevelt Hospital Center | Conditions: Bulimia | Phase 2 | Status: TERMINATED | Results posted: 2017-04-28